Actelion Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on Actelion Pharmaceuticals Ltd in one report.
- Save hours of research time and resources with
our up-to-date Actelion Pharmaceuticals Ltd Strategy Report
- Understand Actelion Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Actelion Pharmaceuticals Ltd (Actelion) is a biopharmaceutical company that focuses on the discovery, development and commercialization of medicines to treat life threatening diseases. The company’s portfolio of PAH products, research and development activities and synergy with parent are its major strengths, even as patent infringement concerns is a cause of concern for the company to look upon. Agreement with Owkin, market potential for rare diseases and orphan drugs, and unmet medical need for duchenne muscular dystrophy provide it growth opportunities. However, uncertainties related to research and development, influx of generics, and competitive pressures could affect the company's profit margins.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward